Clinical trial
A Phase 1 Study to Evaluate the Pharmacodynamics of RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study to Evaluate the Pharmacodynamics of RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- July 31, 2010
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.